Welcome to the NAACP's Tri-County Branch of Alabama, servicing Colbert, Lauderdale, & Franklin Counties. Our mission is to promote the cooperation amongst the citizens of Northwest Alabama, to increase the involvement of each citizen to achieve political, educational, social, and economic equality, and to work toward the elimination of racial hatred and discrimination amongst all people.
The NAACP is here to speak on behalf of those who need their voices amplified. We are here to advocate for those who seek justice. We stand for right. We will not settle complacently for what is when our vision and our faith have shown us what can be. We encourage each of you to stand with us, and to be part of the solution. There are those who make petty and evil attempts to divide and conquer us. We pray that you will “do better, and be better”. There are those who are both selfish and self-serving. We pray that you will evolve. With God on our side, no weapons can harm us. United we stand. And when we choose to fight for right, we will win.
Tori Bailey, President
NAACP Tri-County Branch
The NAACP Tri-County Branch has hosted a series of zoom conversations accessible via Facebook live (see our Facebook page below and scroll down to review). For more information, or to schedule a vaccination, visit HelenKeller.com. The following information can be found on the Alabama Department of Public Health website:
Those currently eligible for vaccine in Alabama are healthcare providers, nursing residents, law enforcement officers, firefighters, persons age 65 and older, and additional of critical workers.
Starting March 22, ADPH extended eligibility for COVID-19 vaccinations to include people 55 and older, people with intellectual and developmental disabilities, and the population as Allocation Phase 1c in the Alabama COVID‐19 Vaccination Allocation Plan which people age 16 to 64 with high-risk medical conditions which include but are not limited to following conditions:
Also, critical workers in the following areas who were not recommended for vaccination in Phase 1b will be eligible:
The Pfizer vaccine is the only COVID-19 vaccine currently approved for age 16 and older. Currently, our county health departments are giving the Moderna vaccine. Other providers, such as hospitals and some pharmacies, are giving the Pfizer vaccine. These other providers may also be offering the Johnson and Johnson vaccine, which is currently not approved for those under 18 years of age. If you are 16 or 17 years of age, please be sure to check which vaccine the provider is offering before scheduling your appointment.
For more information on vaccine planning and prioritization, visit Vaccine Distribution.
For recent news and updates on vaccination in Alabama, visit Vaccination Updates.
Three vaccines have been authorized for emergency use by the U.S. Food & Drug Administration (FDA).
Pfizer-BioNTech COVID-19 Vaccine: The vaccine is authorized for emergency use in persons aged 16 years and older. This is a two-dose vaccine, given 21 days apart. Clinical trial data show the vaccine is 95 percent effective at preventing COVID-19 infection starting seven days after the second dose. Individuals will not be considered fully protected until one to two weeks after they receive the second dose. The clinical trials revealed no major unanticipated adverse events. This vaccine arrived in Alabama on December 14.
Moderna COVID-19 Vaccine: This vaccine is authorized for emergency use in individuals aged 18 years and older. This is a two-dose vaccine, given 28 days apart. Clinical trial data shows the vaccine is about 94 percent effective after two doses. No serious safety concerns were found. This vaccine arrived in Alabama on December 21.
Johnson & Johnson – Janssen COVID-19 Vaccine: This vaccine is authorized for emergency use in individuals age 18 years and older. This is a single dose (one shot) vaccine. You are not considered fully protected until one to two weeks after you get the vaccine. The clinical trials showed no major unanticipated adverse events. This vaccine arrived in Alabama the week of March 1. As of February 27, 2021, large-scale (Phase 3) clinical trials are in progress or being planned for two additional COVID-19 vaccines in the United States.